Similarly, Wise et al. [46] found that four weeks of sulforaphane (25–150 μmoles/day) did not significantly modify Nrf2 gene expression (max average fold change 1.17) in chronic obstructive pulmonary disease patients. Here, NFE2L2 is linked to chronic obstructive pulmonary disease.